NEW YORK (Reuters Health) – Rofecoxib used as adjuvant therapy does not improve survival or reduce recurrences in patients who have undergone surgery for colorectal cancer, according to…
NEW YORK (Reuters Health) – Patients at high risk for pancreatic cancer can be effectively screened with imaging studies and genetic testing, allowing curable neoplasm to be identified…
NEW YORK (Reuters Health) – Atorvastatin plus vitamins C and E reduce the risk of developing hepatitic steatosis in patients with nonalcoholic fatty liver disease, or NAFLD, researchers…
NEW YORK (Reuters Health) – As is seen in certain other gastrointestinal illnesses, the prevalence of low-trauma fractures is higher among patients with chronic pancreatitis than in the…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – If recognized right away, most bile duct injuries related to laparoscopic cholecystectomy should be repaired quickly in a tertiary hepatobiliary center — within…
NEW YORK (Reuters Health) – Among couples wanting to conceive, the routine practice of having men with inflammatory bowel disease discontinue thiopurine medications is not necessary, a Spanish…
NEW YORK (Reuters Health) – For diagnosing the cause of upper abdominal pain, upper endoscopy plus endoscopic ultrasound (EUS) is at least as good as upper endoscopy and…
NEW YORK (Reuters Health) – Patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and biliary stent placement are more likely to develop pancreatitis after the procedure than those not requiring…